{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:41:00Z","timestamp":1776922860237,"version":"3.51.2"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.lfs.2020.118255","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T16:24:01Z","timestamp":1597681441000},"page":"118255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["MicroRNAs and colorectal cancer chemoresistance: New solution for old problem"],"prefix":"10.1016","volume":"259","author":[{"given":"Mostafa","family":"Vaghari-Tabari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Majidinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheila","family":"Moein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durdi","family":"Qujeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zatollah","family":"Asemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forough","family":"Alemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Mohamadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilofar","family":"Targhazeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Safa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118255_bb0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2020.118255_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/643020","article-title":"Colorectal cancer in Iran: molecular epidemiology and screening strategies","volume":"2015","author":"Dolatkhah","year":"2015","journal-title":"J. Cancer Epidemiol."},{"key":"10.1016\/j.lfs.2020.118255_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-2-41","article-title":"Role of APC and DNA mismatch repair genes in the development of colorectal cancers","volume":"2","author":"Narayan","year":"2003","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0020","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ejim.2015.08.019","article-title":"Prevention of colorectal cancer: how many tools do we have in our basket?","volume":"26","author":"Roncucci","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0025","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2016.02.062","article-title":"Colitis-associated and sporadic colon cancers: different diseases, different mutations?","volume":"150","author":"Grivennikov","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118255_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40880-015-0066-y","article-title":"Molecular pathogenesis of sporadic colorectal cancers","volume":"35","author":"Yamagishi","year":"2016","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0035","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3748\/wjg.v23.i28.5086","article-title":"Colorectal cancer screening: an updated review of the available options","volume":"23","author":"Issa","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2020.118255_bb0045","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118255_bb0050","article-title":"Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells","author":"Sakatani","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2020.118255_bb0055","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1002\/jcp.27173","article-title":"MiRNAs and inflammatory bowel disease: an interesting new story","volume":"234","author":"Moein","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2020.118255_bb0060","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.3892\/ol.2017.5895","article-title":"MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase","volume":"13","author":"Xu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2020.118255_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1503\/cmaj.045113","article-title":"The evolving TNM cancer staging system: an essential component of cancer care","volume":"174","author":"Brierley","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.lfs.2020.118255_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11095-018-2404-7","article-title":"Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-\u03b1-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles","volume":"35","author":"Shafiei-Irannejad","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.critrevonc.2012.09.014","article-title":"Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis","volume":"86","author":"Mishra","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lfs.2020.118255_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0035-1564430","article-title":"Chemotherapy for stage II colon cancer","volume":"28","author":"Varghese","year":"2015","journal-title":"Clin. Colon Rectal Surg."},{"key":"10.1016\/j.lfs.2020.118255_bb0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/150845","article-title":"Apoptosis and molecular targeting therapy in cancer","volume":"2014","author":"Hassan","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2020.118255_bb0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3747\/co.v18i1.708","article-title":"Oxaliplatin: a review in the era of molecularly targeted therapy","volume":"18","author":"Alcindor","year":"2011","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1740936","article-title":"Cancer stem cell quiescence and plasticity as major challenges in cancer therapy","volume":"2016","author":"Chen","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.lfs.2020.118255_bb0110","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2008.19.5362","article-title":"Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials","volume":"27","author":"Sargent","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nsmb.3216","article-title":"Mechanistic diversity in ATP-binding cassette (ABC) transporters","volume":"23","author":"Locher","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0120","first-page":"2401","article-title":"Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas","volume":"6","author":"Hinoshita","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0125","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0959-8049(95)00278-Q","article-title":"MDR1\/P-glycoprotein expression in colorectal cancer","volume":"31A","author":"Linn","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/mol.114.096065","article-title":"The c-MET\/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therapy by elevating BCRP\/ABCG2 expression","volume":"87","author":"Jung","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118255_bb0135","first-page":"4071","article-title":"Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells","volume":"29","author":"Prenkert","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.arr.2018.07.010","article-title":"The role of melatonin, a multitasking molecule, in retarding the processes of ageing","volume":"48","author":"Majidinia","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.lfs.2020.118255_bb0145","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.1074\/jbc.RA118.003187","article-title":"ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer","volume":"293","author":"Guo","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118255_bb0150","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1007\/s13277-015-3636-3","article-title":"Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116\/L-OHP cells by preventing activation of NF-kappaB signaling and suppressing cAMP-responsive element transcriptional activity","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0155","doi-asserted-by":"crossref","first-page":"8747","DOI":"10.3892\/mmr.2017.7721","article-title":"MACC1 facilitates chemoresistance and cancer stem celllike properties of colon cancer cells through the PI3K\/AKT signaling pathway","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.dnarep.2014.07.001","article-title":"Akt and p53R2, partners that dictate the progression and invasiveness of cancer","volume":"22","author":"Yousefi","year":"2014","journal-title":"DNA Repair"},{"key":"10.1016\/j.lfs.2020.118255_bb0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.biopha.2014.06.001","article-title":"Glutathione and redox signaling in substance abuse","volume":"68","author":"Uys","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118255_bb0170","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.3892\/mmr.2015.3902","article-title":"Involvement of glutathione and glutathione metabolizing enzymes in human colorectal cancer cell lines and tissues","volume":"12","author":"Kim","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0175","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/BF02236562","article-title":"Relationship between colorectal cancer glutathione levels and patient survival: early results","volume":"43","author":"Barranco","year":"2000","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.lfs.2020.118255_bb0180","first-page":"513","article-title":"Intracellular GSH alterations and its relationship to level of resistance following exposure to cisplatin in cancer cells","volume":"14","author":"Jamali","year":"2015","journal-title":"Iran J. Pharm. Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/972913","article-title":"Role of glutathione in cancer progression and chemoresistance","volume":"2013","author":"Traverso","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2020.118255_bb0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jnc.14250","article-title":"Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis","volume":"144","author":"Zhu","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0195","doi-asserted-by":"crossref","first-page":"25215","DOI":"10.1074\/jbc.M512627200","article-title":"p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65","volume":"281","author":"Cai","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118255_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10520295.2018.1493220","article-title":"Expression of CYP and GST in human normal and colon tumor tissues","volume":"94","author":"Bulus","year":"2019","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0205","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/bjc.2014.386","article-title":"Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines","volume":"111","author":"Sawers","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0210","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1200\/JCO.2004.05.064","article-title":"Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis","volume":"22","author":"Popat","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0215","first-page":"4116","article-title":"Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil","volume":"9","author":"Kornmann","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0220","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase","volume":"6","author":"Salonga","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0225","first-page":"5267","article-title":"Determination of thymidine phosphorylase expression level facilitates recurrence risk stratification in stage II\/III colorectal cancer following adjuvant chemotherapy with oral fluoropyrimidines","volume":"17","author":"Kugimiya","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2020.118255_bb0230","doi-asserted-by":"crossref","first-page":"32622","DOI":"10.18632\/oncotarget.5327","article-title":"Acquired resistance to 5-fluorouracil via HSP90\/Src-mediated increase in thymidylate synthase expression in colon cancer","volume":"6","author":"Ahn","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0235","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.surg.2005.10.012","article-title":"Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer","volume":"139","author":"Douard","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.lfs.2020.118255_bb0240","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41598-018-38017-0","article-title":"FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression","volume":"9","author":"Varghese","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0245","doi-asserted-by":"crossref","first-page":"8574","DOI":"10.18632\/oncotarget.14351","article-title":"FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0250","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Marechal","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0255","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0260","first-page":"145","article-title":"The role of p53 in apoptosis","volume":"9","author":"Amaral","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0265","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2254","article-title":"Role of autophagy in cancer","volume":"7","author":"Mathew","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0270","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.24064","article-title":"Tumor resistance to apoptosis","volume":"124","author":"Fulda","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.ircmb.2016.06.006","article-title":"Metabolic regulation of apoptosis in Cancer","volume":"327","author":"Matsuura","year":"2016","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0280","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.acthis.2011.01.002","article-title":"Prognostic significance of Bcl-xL gene expression in human colorectal cancer","volume":"113","author":"Jin-Song","year":"2011","journal-title":"Acta Histochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0285","doi-asserted-by":"crossref","first-page":"e2342","DOI":"10.1038\/cddis.2016.233","article-title":"Bcl-xL is an oncogenic driver in colorectal cancer","volume":"7","author":"Scherr","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118255_bb0290","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ijc.10146","article-title":"Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status","volume":"98","author":"Violette","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0295","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/cdd.2014.170","article-title":"Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer","volume":"22","author":"Wu","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2020.118255_bb0300","article-title":"Mutant p53 in colon cancer","author":"Nakayama","year":"2018","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1471-2407-13-277","article-title":"Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer","volume":"13","author":"Sarasqueta","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0310","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/(SICI)1097-0215(19960621)69:3<190::AID-IJC7>3.0.CO;2-V","article-title":"p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas","volume":"69","author":"Benhattar","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0315","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1158\/1078-0432.CCR-03-0362","article-title":"Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan","volume":"10","author":"Boyer","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-2187-7-12","article-title":"Understanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine","volume":"7","author":"Stamelos","year":"2012","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.lfs.2020.118255_bb0325","article-title":"Autophagy facilitates anticancer effect of 5-fluorouracil in HCT-116 cells","volume":"14","author":"Yang","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.lfs.2020.118255_bb0330","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1038\/srep04694","article-title":"JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy","volume":"4","author":"Sui","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0335","doi-asserted-by":"crossref","first-page":"ra121","DOI":"10.1126\/scisignal.aaa1877","article-title":"Systematic identification of signaling pathways with potential to confer anticancer drug resistance","volume":"7","author":"Martz","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.lfs.2020.118255_bb0340","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2174\/13816128112092464","article-title":"Role of Wnt\/beta-catenin signaling in drug resistance of pancreatic cancer","volume":"18","author":"Cui","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2020.118255_bb0345","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fonc.2013.00120","article-title":"Targeting nuclear factor-kappa B to overcome resistance to chemotherapy","volume":"3","author":"Godwin","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0350","first-page":"2041","article-title":"Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells","volume":"30","author":"Chikazawa","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0355","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/cas.13097","article-title":"Wnt-beta-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer","volume":"107","author":"Kobayashi","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2020.118255_bb0360","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11010-018-3365-1","article-title":"Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-kappaB signal transduction","volume":"449","author":"Liu","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0365","first-page":"2102","article-title":"ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NFkappaB signaling pathway","volume":"53","author":"Wang","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0370","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1002\/jcb.26783","article-title":"Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116","volume":"119","author":"Kukcinaviciute","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0375","article-title":"Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway","author":"Xu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0380","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.2147\/OTT.S108929","article-title":"CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK\/MEK\/ERK signal pathway in colorectal cancer","volume":"9","author":"Yang","year":"2016","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.lfs.2020.118255_bb0385","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160447","article-title":"Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K\/AKT signaling pathway","volume":"37","author":"Xu","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0390","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/ars.2011.3952","article-title":"Peroxiredoxin-2 upregulated by NF-kappaB attenuates oxidative stress during the differentiation of muscle-derived C2C12 cells","volume":"16","author":"Won","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2020.118255_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4251912","article-title":"Redox control of multidrug resistance and its possible modulation by antioxidants","volume":"2016","author":"Cort","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2020.118255_bb0400","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/875961","article-title":"New insights for oxidative stress and diabetes mellitus","volume":"2015","author":"Maiese","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2020.118255_bb0405","article-title":"Evaluation of the potential antioxidant role of high-density lipoprotein-cholesterol (HDL-C) in patients with ulcerative colitis","volume":"5","author":"Vaghari Tabari","year":"2017","journal-title":"Ann. Colorectal Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0410","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.amjms.2017.12.009","article-title":"Positive correlation of fecal calprotectin with serum antioxidant enzymes in patients with inflammatory bowel disease: accidental numerical correlation or a new finding?","volume":"355","author":"Vaghari-Tabari","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.lfs.2020.118255_bb0415","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1038\/cddis.2013.509","article-title":"Antioxidants decrease the apoptotic effect of 5-Fu in colon cancer by regulating Src-dependent caspase-7 phosphorylation","volume":"5","author":"Fu","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118255_bb0420","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317705510","article-title":"The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance","volume":"39","author":"Sadeghi","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0425","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/03602532.2016.1197239","article-title":"Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters","volume":"48","author":"Bai","year":"2016","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.lfs.2020.118255_bb0430","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0435","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/PAI.0b013e318282ac20","article-title":"Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue","volume":"21","author":"Chang","year":"2013","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.lfs.2020.118255_bb0440","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biopha.2018.05.062","article-title":"Nrf2\/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer","volume":"104","author":"Sadeghi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118255_bb0445","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1038\/cddis.2014.149","article-title":"Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation","volume":"5","author":"Kang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118255_bb0450","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","article-title":"Cancer stem cells: the root of tumor recurrence and metastases","volume":"44","author":"Peitzsch","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124036","article-title":"Targeting cancer stem cells to overcome chemoresistance","volume":"19","author":"Nunes","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2020.118255_bb0460","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1007\/s00018-014-1636-x","article-title":"Colitis-associated neoplasia: molecular basis and clinical translation","volume":"71","author":"Foersch","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2020.118255_bb0465","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2015.05.005","article-title":"Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy","volume":"364","author":"James","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2020.118255_bb0470","first-page":"1","article-title":"RAS\/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression","volume":"235","author":"Rezatabar","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2020.118255_bb0475","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/carcin\/bgv006","article-title":"Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer","volume":"36","author":"Toden","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2020.118255_bb0480","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3892\/ol.2013.1145","article-title":"Huaier aqueous extract inhibits colorectal cancer stem cell growth partially via downregulation of the Wnt\/beta-catenin pathway","volume":"5","author":"Zhang","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2020.118255_bb0485","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3727\/096504016X14772331883976","article-title":"Overexpression of PER3 inhibits self-renewal capability and chemoresistance of colorectal cancer stem-like cells via inhibition of notch and beta-catenin Signaling","volume":"25","author":"Zhang","year":"2017","journal-title":"Oncol. Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0490","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.3892\/mmr.2015.3890","article-title":"MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5","volume":"12","author":"Yang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0495","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12341","article-title":"miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1\/P-gp expression","volume":"50","author":"Zhou","year":"2017","journal-title":"Cell Prolif."},{"key":"10.1016\/j.lfs.2020.118255_bb0500","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/mol.112.081844","article-title":"MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells","volume":"83","author":"Ikemura","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118255_bb0505","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/1535-7163.MCT-14-0167","article-title":"miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2\/c-Jun signaling pathway in colorectal cancer","volume":"13","author":"Sui","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2020.118255_bb0510","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/138920371604150429153309","article-title":"Elevated microRNA-23a expression enhances the chemoresistance of colorectal cancer cells with microsatellite instability to 5-fluorouracil by directly targeting ABCF1","volume":"16","author":"Li","year":"2015","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.lfs.2020.118255_bb0515","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/jcb.24721","article-title":"MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1\/caspase-9 apoptotic pathway in colorectal cancer cells","volume":"115","author":"Shang","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0520","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/BJ20120386","article-title":"miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2","volume":"446","author":"Xu","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2020.118255_bb0525","doi-asserted-by":"crossref","first-page":"52983","DOI":"10.18632\/oncotarget.17677","article-title":"miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0530","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yexcr.2015.09.011","article-title":"Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer","volume":"338","author":"To","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0535","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mc.22508","article-title":"A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development","volume":"56","author":"To","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lfs.2020.118255_bb0540","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00109-013-1037-x","article-title":"MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells","volume":"91","author":"Shen","year":"2013","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.lfs.2020.118255_bb0545","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317715155","article-title":"Upregulation of miR-199a\/b contributes to cisplatin resistance via Wnt\/beta-catenin-ABCG2 signaling pathway in ALDHA1(+) colorectal cancer stem cells","volume":"39","author":"Chen","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0550","first-page":"2050","article-title":"miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells","volume":"41","author":"Lin","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0555","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.biopha.2018.09.112","article-title":"Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p","volume":"108","author":"Ghanbarian","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118255_bb0560","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/or.2014.3646","article-title":"miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer","volume":"33","author":"Li","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0565","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s12094-015-1318-7","article-title":"MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer","volume":"17","author":"Sun","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0570","doi-asserted-by":"crossref","first-page":"74312","DOI":"10.18632\/oncotarget.19670","article-title":"Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0575","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1158\/1535-7163.MCT-10-0061","article-title":"miR-192\/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation","volume":"9","author":"Boni","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2020.118255_bb0580","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/iub.1361","article-title":"MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD","volume":"67","author":"Chai","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.lfs.2020.118255_bb0585","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/OTT.S159093","article-title":"miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells","volume":"11","author":"Meng","year":"2018","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.lfs.2020.118255_bb0590","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biopha.2015.07.036","article-title":"miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1","volume":"75","author":"Tong","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118255_bb0595","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/cdd.2011.28","article-title":"MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer","volume":"18","author":"Zhang","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2020.118255_bb0600","first-page":"4363","article-title":"miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin","volume":"17","author":"Yao","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0605","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1111\/j.1742-4658.2009.07383.x","article-title":"MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells","volume":"276","author":"Borralho","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2020.118255_bb0610","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ijc.25143","article-title":"Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells","volume":"127","author":"Nakano","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0615","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1158\/1541-7786.MCR-13-0061","article-title":"Tumor suppressor functions of miR-133a in colorectal cancer","volume":"11","author":"Dong","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0620","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.biopha.2018.03.028","article-title":"GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer","volume":"101","author":"Feng","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118255_bb0625","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3892\/or.2016.4810","article-title":"MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein","volume":"36","author":"Han","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0630","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2010.10.006","article-title":"Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells","volume":"300","author":"Akao","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2020.118255_bb0635","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.2147\/OTT.S188054","article-title":"lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a\/ATG4B pathway","volume":"12","author":"Li","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.lfs.2020.118255_bb0640","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1111\/jcmm.14071","article-title":"LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760\/PPP1R1B via the cAMP signalling pathway","volume":"23","author":"Xian","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0645","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40781-018-0183-7","article-title":"Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review","volume":"60","author":"Dhanoa","year":"2018","journal-title":"J. Anim. Sci. Technol."},{"key":"10.1016\/j.lfs.2020.118255_bb0650","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1038\/cddis.2013.193","article-title":"miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer","volume":"4","author":"Karaayvaz","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118255_bb0655","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.18632\/oncotarget.22322","article-title":"Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells","volume":"9","author":"Wu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0660","first-page":"7240","article-title":"Overexpression of miR-215-3p sensitizes colorectal cancer to 5-fluorouracil induced apoptosis through regulating CXCR1","volume":"22","author":"Li","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2020.118255_bb0665","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.7150\/thno.20942","article-title":"Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2020.118255_bb0670","article-title":"Systemic administration of miRNA mimics by liposomal delivery system in animal model of colorectal carcinoma","volume":"65","author":"Merhautova","year":"2016","journal-title":"Physiol. Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0675","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/cam4.1809","article-title":"Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0680","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1159\/000489110","article-title":"LncRNA HOTAIR is a prognostic biomarker for the proliferation and chemoresistance of colorectal cancer via MiR-203a-3p-mediated Wnt\/ss-catenin signaling pathway","volume":"46","author":"Xiao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0685","article-title":"Propofol promotes apoptosis of colorectal cancer cells via alleviating the suppression of lncRNA HOXA11-AS on miRNA let-7i","author":"Ren","year":"2019","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0690","first-page":"2992","article-title":"miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway","volume":"8","author":"Zhou","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0695","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/ars.2016.6797","article-title":"NFE2L2\/NRF2 activity is linked to mitochondria and AMP-activated protein kinase Signaling in cancers through miR-181c\/mitochondria-encoded cytochrome c oxidase regulation","volume":"27","author":"Jung","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2020.118255_bb0705","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.yexcr.2017.09.023","article-title":"miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin","volume":"360","author":"Han","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0710","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1074\/jbc.M114.620252","article-title":"MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer","volume":"290","author":"Zhang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118255_bb0715","first-page":"1382","article-title":"MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2","volume":"5","author":"He","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118255_bb0720","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.febslet.2011.08.014","article-title":"miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells","volume":"585","author":"Liu","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2020.118255_bb0725","doi-asserted-by":"crossref","first-page":"e1845","DOI":"10.1038\/cddis.2015.200","article-title":"MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer","volume":"6","author":"Zhang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2020.118255_bb0730","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.canlet.2014.10.029","article-title":"MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells","volume":"356","author":"Zhang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2020.118255_bb0735","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3892\/ijmm.2016.2492","article-title":"miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy","volume":"37","author":"Tan","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0740","doi-asserted-by":"crossref","first-page":"19735","DOI":"10.18632\/oncotarget.3771","article-title":"Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy","volume":"6","author":"Zhai","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0745","article-title":"CXCL12\/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0750","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12885-016-2123-6","article-title":"MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells","volume":"16","author":"Nyhan","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0755","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.18632\/oncotarget.6732","article-title":"miR-183 regulates autophagy and apoptosis in colorectal cancer through targeting of UVRAG","volume":"7","author":"Huangfu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0760","first-page":"2655","article-title":"Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-kappaB signalling pathway and inducing apoptosis","volume":"15","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023787","article-title":"miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation","volume":"6","author":"Borralho","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118255_bb0770","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.omtn.2017.07.007","article-title":"lncRNA HOTAIR contributes to 5FU resistance through suppressing miR-218 and activating NF-kappaB\/TS signaling in colorectal cancer","volume":"8","author":"Li","year":"2017","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.lfs.2020.118255_bb0775","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/j.gastro.2014.06.006","article-title":"A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFkappaB and STAT3 in colorectal cancer cells","volume":"147","author":"Liu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118255_bb0780","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.prp.2016.04.011","article-title":"miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1","volume":"212","author":"Liu","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.lfs.2020.118255_bb0785","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijbiomac.2018.05.151","article-title":"Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling","volume":"117","author":"Jin","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2020.118255_bb0790","article-title":"miR-139-5p inhibits the epithelial-mesenchymal transition and enhances the chemotherapeutic sensitivity of colorectal cancer cells by downregulating BCL2","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0795","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13045-019-0708-7","article-title":"miR-195-5p\/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0800","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2014.11.039","article-title":"miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1","volume":"457","author":"Wan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.118255_bb0805","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2011.02.003","article-title":"miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression","volume":"304","author":"Li","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2020.118255_bb0810","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11010-011-0872-8","article-title":"Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells","volume":"357","author":"Li","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2020.118255_bb0815","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.18632\/oncotarget.1614","article-title":"MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0820","article-title":"Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-fluorouracil through the PTEN\/PI3K\/AKT pathway","volume":"39","author":"Liu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.lfs.2020.118255_bb0825","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12943-015-0372-7","article-title":"miR-21 and miR-145 cooperation in regulation of colon cancer stem cells","volume":"14","author":"Yu","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0830","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/dna.2015.3120","article-title":"miR-450b-5p suppresses stemness and the development of chemoresistance by targeting SOX2 in colorectal cancer","volume":"35","author":"Jin","year":"2016","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.lfs.2020.118255_bb0835","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jcmm.13968","article-title":"MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22\/Wnt\/beta-catenin signaling axis","volume":"23","author":"Jiang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118255_bb0840","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/gutjnl-2011-301846","article-title":"MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis","volume":"62","author":"Hur","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2020.118255_bb0845","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/carcin\/bgr246","article-title":"MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells","volume":"33","author":"Yu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2020.118255_bb0850","doi-asserted-by":"crossref","first-page":"45199","DOI":"10.18632\/oncotarget.9900","article-title":"MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118255_bb0855","first-page":"1484","article-title":"MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5","volume":"36","author":"Li","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2020.118255_bb0860","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1245\/s10434-012-2246-1","article-title":"MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells","volume":"19","author":"Nishida","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0865","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.molonc.2013.02.016","article-title":"High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer","volume":"7","author":"Rasmussen","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0870","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebiom.2018.08.042","article-title":"Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients","volume":"35","author":"Ji","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lfs.2020.118255_bb0875","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.12659\/MSM.900674","article-title":"The clinical significance of MiR-429 as a predictive biomarker in colorectal cancer patients receiving 5-fluorouracil treatment","volume":"22","author":"Dong","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.lfs.2020.118255_bb0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046684","article-title":"The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer","volume":"7","author":"Takahashi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118255_bb0885","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12032-013-0549-0","article-title":"MicroRNA-215 inhibits relapse of colorectal cancer patients following radical surgery","volume":"30","author":"Li","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0890","first-page":"68","article-title":"Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients","volume":"7","author":"Lopes-Ramos","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.lfs.2020.118255_bb0895","article-title":"The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118255_bb0900","article-title":"Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis","volume":"6","author":"Cheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118255_bb0905","first-page":"1437","article-title":"MicroRNA miR-125b is a prognostic marker in human colorectal cancer","volume":"38","author":"Nishida","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2020.118255_bb0910","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2407-12-83","article-title":"The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer","volume":"12","author":"Hansen","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2020.118255_bb0915","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/bjc.2014.652","article-title":"Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer","volume":"112","author":"Hansen","year":"2015","journal-title":"Br. J. Cancer"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T10:21:50Z","timestamp":1717237310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520310079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":180,"alternative-id":["S0024320520310079"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118255","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs and colorectal cancer chemoresistance: New solution for old problem","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118255"}}